NK Cells in Cancer Immunotherapy: Successes and Challenges 1st Edition

NK Cells in Cancer Immunotherapy: Successes and Challenges, 1st Edition by Anahid Jewett and Yuman Fong delivers a timely, authoritative exploration of natural killer (NK) cell biology and its translation into cutting-edge cancer immunotherapies. Perfect for clinicians, researchers, and graduate students worldwide, this volume synthesizes current science with clinical perspectives to illuminate both breakthroughs and persistent obstacles in immuno-oncology.

Discover clear, evidence-based analysis of how NK cells target tumors, interact with the tumor microenvironment, and are engineered for therapeutic use. The book examines successful clinical applications, discusses the design of NK cell–based cellular therapies, and outlines strategies to overcome immune suppression and improve patient outcomes. Readers will find balanced coverage of preclinical models, translational challenges, and the latest clinical trial insights—making it indispensable for oncologists, immunologists, and biotech developers.

What sets this edition apart is its practical orientation: it not only reviews mechanisms and trial data but also offers conceptual frameworks for designing next-generation NK cell therapies. Whether you are seeking to implement NK approaches in the clinic, develop novel therapeutics, or stay current in cancer immunotherapy, this book provides actionable knowledge grounded in rigorous science.

Add NK Cells in Cancer Immunotherapy to your professional library to stay at the forefront of immuno-oncology advances. Ideal for readers in North America, Europe, Asia, and beyond, this edition equips you to navigate the successes and challenges shaping the future of cancer treatment. Order your copy today.

Note: eBooks do not include supplementary materials such as CDs, access codes, etc.